A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer

A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer

Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment strategies are desperately needed due to limited standard therapies. Activation of the Erk, Akt, and STAT3pathways is implicated in the prognosis of HCC. The Se,Se′-1,4-phenylenebis(1,2-ethanediyl) bisisoselen...

Full description

Bibliographic Details
Main Authors: Hephzibah Rani S. Tagaram, Dhimant Desai, Guangfu Li, Dai Liu, C. Bart Rountree, Kavitha Gowda, Arthur Berg, Shantu Amin, Kevin F. Staveley-O’Carroll, Eric T. Kimchi
Format: Article
Language:English
Published: MDPI AG 2016-03-01
Series:Pharmaceuticals
Subjects:
inhibition
hepatocellular cancer
selenium
apoptotic and angiogenesis markers
Online Access:http://www.mdpi.com/1424-8247/9/2/18

Internet

http://www.mdpi.com/1424-8247/9/2/18

Similar Items